{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:20:46Z","timestamp":1787700046654,"version":"build-2784847793"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["RBSI14022M"],"award-info":[{"award-number":["RBSI14022M"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.01031","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T04:31:33Z","timestamp":1526013093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming"],"prefix":"10.3389","volume":"9","author":[{"given":"Cristina","family":"Capuano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Battella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Franchitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Turriziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricciarda","family":"Galandrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.it.2016.01.005","article-title":"Immune adaptation to environmental influence: the case of NK cells and HCMV","volume":"37","author":"R\u00f6lle","year":"2016","journal-title":"Trends Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2015.9","article-title":"Natural killer cell memory in infection, inflammation and cancer","volume":"16","author":"Cerwenka","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.it.2016.04.006","article-title":"Epigenetic regulation of adaptive NK cell diversification","volume":"37","author":"Tesi","year":"2016","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human Cytomegalovirus infection","volume":"108","author":"Lopez-Verg\u00e8s","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/intimm\/dxs080","article-title":"Identification of human NK cells that are deficient for signaling adaptor FcR\u03b3 and specialized for antibody-dependent immune functions","volume":"24","author":"Hwang","year":"2012","journal-title":"Int Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.4049\/jimmunol.1203034","article-title":"Cutting edge: antibody-dependent memory-like NK cells distinguished by FcR\u03b3 deficiency","volume":"190","author":"Zhang","year":"2013","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","article-title":"Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human Cytomegalovirus-infected individuals","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.4049\/jimmunol.1502438","article-title":"Relationship of NKG2C copy number with the distribution of distinct Cytomegalovirus-induced adaptive NK cell subsets","volume":"196","author":"Muntasell","year":"2016","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK cells in response to human Cytomegalovirus-infected fibroblasts","volume":"107","author":"Gum\u00e1","year":"2006","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1172\/JCI77440","article-title":"IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion","volume":"124","author":"R\u00f6lle","year":"2014","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/eji.201141826","article-title":"CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients","volume":"42","author":"B\u00e9ziat","year":"2012","journal-title":"Eur J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.4049\/jimmunol.1402448","article-title":"An NK cell population lacking FcR\u03b3 is expanded in chronically infected HIV patients","volume":"194","author":"Zhou","year":"2015","journal-title":"J Immunol"},{"key":"B15","first-page":"218","article-title":"Receptors for the Fc fragment of IgG on natural killer cells","volume":"12","author":"Trinchieri","year":"1993","journal-title":"Nat Immun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming","volume":"5","author":"Mart\u00edn-Fontecha","year":"2004","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fimmu.2016.00235","article-title":"\u201cNatural regulators\u201d: NK cells as modulators of T cell immunity","volume":"7","author":"Schuster","year":"2016","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.162.2.735","article-title":"Quantitative analysis of the effect of CD16 ligation on human NK cell proliferation","volume":"162","author":"Warren","year":"1999","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"11075","DOI":"10.1038\/s41598-017-09259-1","article-title":"Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.4049\/jimmunol.147.8.2652","article-title":"Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII)","volume":"147","author":"Letourneur","year":"1991","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.celrep.2016.04.005","article-title":"Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans","volume":"15","author":"Liu","year":"2016","journal-title":"Cell Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1004441","DOI":"10.1371\/journal.ppat.1004441","article-title":"Human Cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells","volume":"10","author":"Luetke-Eversloh","year":"2014","journal-title":"PLoS Pathog"},{"key":"B24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.coi.2008.05.011","article-title":"Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies","volume":"20","author":"Taylor","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc3930","article-title":"Building better monoclonal antibody-based therapeutics","volume":"15","author":"Weiner","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3389\/fimmu.2017.01245","article-title":"Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going?","volume":"8","author":"Marshall","year":"2017","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.5VMR0415-141R","article-title":"Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions","volume":"99","author":"Battella","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1182\/blood-2009-10-248609","article-title":"Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response","volume":"116","author":"Ab\u00e8s","year":"2010","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2015.00013","article-title":"Natural killer cells as helper cells in dendritic cell cancer vaccines","volume":"6","author":"Pampena","year":"2015","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3324\/haematol.2011.050419","article-title":"Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone","volume":"97","author":"Persky","year":"2012","journal-title":"Haematologica"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","article-title":"Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions","volume":"370","author":"Goede","year":"2014","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1470-2045(16)30097-3","article-title":"Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial","volume":"17","author":"Sehn","year":"2016","journal-title":"Lancet Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the first-line treatment of follicular lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4161\/mabs.22771","article-title":"Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties","volume":"5","author":"Klein","year":"2013","journal-title":"MAbs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1158\/0008-5472.CAN-15-0781","article-title":"Anti-CD20 therapy acts via Fc\u03b3RIIIA to diminish responsiveness of human natural killer cells","volume":"75","author":"Capuano","year":"2015","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1290037","DOI":"10.1080\/2162402X.2017.1290037","article-title":"Obinutuzumab-mediated high-affinity ligation of Fc\u03b3RIIIA\/CD16 primes NK cells for IFN\u03b3 production","volume":"6","author":"Capuano","year":"2017","journal-title":"Oncoimmunology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jim.2005.08.004","article-title":"Flow cytometric assay for determination of FcgammaRIIIA-158 V\/F polymorphism","volume":"306","author":"B\u00f6ttcher","year":"2005","journal-title":"J Immunol Methods"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fimmu.2017.00458","article-title":"Shaping of natural killer cell antitumor activity by Ex vivo cultivation","volume":"8","author":"Granzin","year":"2017","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7157","DOI":"10.1038\/srep07157","article-title":"Homotypic NK cell-to-cell communication controls cytokine responsiveness of innate immune NK cells","volume":"4","author":"Kim","year":"2014","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1158\/2326-6066.CIR-16-0296","article-title":"Ex vivo expanded adaptive NK cells effectively kill primary acute lymphoblastic leukemia cells","volume":"5","author":"Liu","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.4049\/jimmunol.1400288","article-title":"KIR\/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody- dependent cellular cytotoxicity","volume":"192","author":"Terszowski","year":"2014","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.181.1.339","article-title":"Receptor-induced death in human natural killer cells: involvement of CD16","volume":"181","author":"Ortaldo","year":"1995","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1182\/blood-2015-09-670802","article-title":"Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions","volume":"126","author":"Freeman","year":"2015","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2014-07-588376","article-title":"Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies","volume":"125","author":"Tipton","year":"2015","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1172\/JCI64837","article-title":"Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity","volume":"122","author":"Grier","year":"2012","journal-title":"J Clin Invest"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1","article-title":"NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells","volume":"29","author":"Sivori","year":"1999","journal-title":"Eur J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:57:38Z","timestamp":1720288658000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.01031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2018.01031"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.01031","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,11]]},"article-number":"1031"}}